Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

Overview of attention for article published in OncoTargets and therapy, June 2013

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 10 Mendeley

Summary Facebook Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction

Article in Frontiers in Medicine (October 2021)

CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

Article in European Radiology (August 2020)

Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment.

Article in Current Vascular Pharmacology (January 2019)